greeksoup/ stock research
Stock research / United States / Funds / Anchorage Capital Group, L.L.C.

Anchorage Capital Group, L.L.C.

CIK 1300714 · latest 13F filed 14 August 2026 · Read the filing on EDGAR

Anchorage Capital Group, L.L.C. reported 3 US-listed holdings worth $450.5 million in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Equipmentshare Com Inc. (77.6%), Sentinelone Inc. (18.6%) and Ginkgo Bioworks Holdings Inc (3.8%). Against the quarter before, it opened 0 positions, added to 0, trimmed 0 and sold out of 0.

Reported holdings$450.5M+3.2% on Q1 2026
Positions3as many as Q1 2026
The largest ten100.0%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Where the money is
Held
EQPT77.6%S18.6%DNA3.8%

The 3 largest of its 3 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $374.9 million in 6 positions$375MQ3 24Q4 2024: $272.5 million in 6 positions$273MQ4 24Q1 2025: $239.9 million in 6 positions$240MQ1 25Q2 2025: $258.7 million in 6 positions$259MQ2 25Q3 2025: $117.4 million in 4 positions$117MQ3 25Q4 2025: $88.6 million in 2 positions$88.6MQ4 25Q1 2026: $436.3 million in 3 positions$436MQ1 26Q2 2026: $450.5 million in 3 positions$450MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned -30.3% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
6080100120Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings -30.3%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it holds

CompanySharesValueOf its bookChange in shares
Equipmentshare Com Inc. EQPT17.8M$349.4 million77.56%no change
Sentinelone Inc. S4.9M$83.8 million18.60%no change
Ginkgo Bioworks Holdings Inc DNA1.7M$17.3 million3.84%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before.